N. Shepperson

发表

The in vivo pharmacological profile of eletriptan (UK-116,044): a potent and novel 5-HT(1B/1D) receptor agonist.

A. Mcharg, P. Gupta, P. Butler, 2000, European journal of pharmacology.

The in vivo pharmacological profile of a 5‐HT1 receptor agonist, CP‐122, 288, a selective inhibitor of neurogenic inflammation

S. Robson, J. Macor, M. Wythes, 1995, British journal of pharmacology.

The effects of a new opioid analgesic, meptazinol, on the respiration of the conscious rat

N. Shepperson, I. Cowlrick, I.S. Cowlrick, 1985, British journal of pharmacology.

In vivo selectivity of prazosin but not of WB4101 for postsynaptic alpha-1 adrenoceptors.

M. Dubocovich, S. Z. Langer, N. Shepperson, 1981, The Journal of pharmacology and experimental therapeutics.

Presence of postsynaptic alpha 2-adrenoreceptors of predominantly extrasynaptic location in the vascular smooth muscle of the dog hind limb.

S. Z. Langer, N. Shepperson, R. Massingham, 1980, Clinical science.

Postjunctional α1- and α2-Adrenoceptors: Preferential Innervation of α1-Adrenoceptors and the Role of Neuronal Uptake

S. Z. Langer, N. Shepperson, 1982 .

Recent developments in vascular smooth muscle pharmacology: the post-synaptic α2-adrenoceptor

S. Z. Langer, N. Shepperson, 1982 .

The effect of indoramin on plasma lipids in hypercholesterolemic patas monkeys

N. Shepperson, V. Pierce, Andrew West‐Watson, 1985, The Journal of pharmacy and pharmacology.

Preferential Noradrenergic Innervation of Alpha‐Adrenergic Receptors in Vascular Smooth Muscle

S. Z. Langer, N. Shepperson, R. Massingham, 1981, Hypertension.

α2‐Adrenoceptor agonists potentiate responses mediated by α1‐adrenoceptors in the cat nictitating membrane

N. Shepperson, 1984 .

Dopamine decreases mesenteric blood flow in the anaesthetised dog through the stimulation of postsynaptic alpha 2-adrenoceptors.

S. Z. Langer, N. Duval, N. Shepperson, 1982, European journal of pharmacology.

Renal effects of neutral endopeptidase inhibition in euvolemic and hypervolemic rats.

J. Scott, N. Shepperson, P. Barclay, 1993, European journal of pharmacology.

Inhibition of neutral endopeptidase (EC 3.4.24.11) leads to an atrial natriuretic factor-mediated natriuretic, diuretic and antihypertensive response in rodents.

J. Bennett, N. Shepperson, P. Barclay, 1991, Clinical science.

Cardiovascular effects of human and rat CGRP compared in the rat and other species.

R. Craig, N. Shepperson, I. Marshall, 1986, European journal of pharmacology.

The atriopeptidase inhibitor (+/-) candoxatrilat reduces the clearance of atrial natriuretic factor in both intact and nephrectomized rats: evidence for an extrarenal site of action.

J. Bennett, N. Shepperson, P. Barclay, 1991, Biochemical pharmacology.

The pharmacokinetics of 125I-atrial natriuretic factor in anaesthetized rats. Effects of neutral endopeptidase inhibition with candoxatrilat and of ANF-C receptor blockade.

J. Bennett, N. Shepperson, P. Greengrass, 1992, Biochemical pharmacology.

The Role of Presynaptic Receptors in the Modulation of Neurotransmission

S. Z. Langer, N. Shepperson, 1982 .

SUBCLASSIFICATION OF ALPHA-ADRENOCEPTORS IN ALPHA1 AND ALPHA2 SUBCATEGORIES: PHYSIOLOGICAL AND PHARMACOLOGICAL IMPLICATIONS

S. Z. Langer, N. Shepperson, R. Massingham, 1981 .

The effects of the 2-amino-tetrahydronaphthalene derivative M7, a selective α2-adrenoceptor agonist in vitro

S. Z. Langer, N. Shepperson, 1981, Naunyn-Schmiedeberg's Archives of Pharmacology.

The alpha 2-adrenoceptor selectivities and haemodynamic effects of WY26392 and yohimbine in the anaesthetised dog.

N. Shepperson, P. Paciorek, 1985, European Journal of Pharmacology.

An investigation into the selectivity of a novel series of benzoquinolizines for α2‐adrenoceptors in vivo

N. Shepperson, V. Pierce, P. Paciorek, 1984, British journal of pharmacology.

THE EFFECTS OF RELEASE AND DEPLETION OF ENDOGENOUS NORADRENALINE ON THE TRANSMISSION OF IMPULSES IN THE MOUSE VAS DEFERENS

P. Nasmyth, N. Shepperson, I. Marshall, 1978, British journal of pharmacology.

α‐ADRENOCEPTORS IN THE MOUSE VAS DEFERENS AND THEIR EFFECTS ON ITS RESPONSE TO ELECTRICAL STIMULATION

C. Nicholl, P. Nasmyth, N. Shepperson, 1978, British journal of pharmacology.

Pre-synaptic a-adrenoceptors andthe inhibition byuptake blocking agents ofthetwitch response ofthemouse vasdeferens

P. Nasmyth, N. Shepperson, 1977 .

In vitro studies on 6-fluoronoradrenaline at several peripheral sympathetic neuroeffector junctions

S. Z. Langer, N. Shepperson, R. Massingham, 1981, Naunyn-Schmiedeberg's Archives of Pharmacology.

A comparison of 3 methods used for measuring the overflow of noradrenaline in the mouse isolated stimulated vas deferens [proceedings].

P. Nasmyth, N. Shepperson, I. Marshall, 1978, British journal of pharmacology.

The natriuretic and diuretic responses to the atriopeptidase inhibitor UK-69,578 in volume expanded rats.

J. Bennett, N. Shepperson, J. Danilewicz, 1989, British journal of pharmacology.

The apparent metabolisable energy of sunflower oil and sunflower acid oil for broiler chickens

J. Wiseman, N. Shepperson, B. Edmunds, 1992 .

Effect of a 5‐HT1 receptor agonist, CP‐122,288, on oedema formation induced by stimulation of the rat saphenous nerve

S. Brain, N. Shepperson, R. Kajekar, 1995, British journal of pharmacology.

Design of an antithrombotic-antihypertensive agent (Wy 27569). Synthesis and evaluation of a series of 2-heteroaryl-substituted dihydropyridines.

J. White, N. Shepperson, C. Ennis, 1990, Journal of medicinal chemistry.

Differential inhibition of vascular smooth muscle responses to alpha 1- and alpha 2-adrenoceptor agonists by diltiazem and verapamil.

S. Z. Langer, N. Shepperson, I. Cavero, 1983, Circulation research.

Investigation into the cardioregulatory properties of the α1‐adrenoceptor blocker indoramin

N. Shepperson, V. Pierce, J. F. Waterfall, 1986 .

α1‐Adrenoceptor agonist activity of α2‐adrenoceptor antagonists in the pithed rat preparation

N. Shepperson, P. Paciorek, 1983 .

Pre- and postsynaptic alpha adrenoceptor selectivity studies with yohimbine and its two diastereoisomers rauwolscine and corynanthine in the anesthetized dog.

S. Z. Langer, N. Duval, N. Shepperson, 1981, The Journal of pharmacology and experimental therapeutics.

Differential Inhibition of Vascular Smooth Muscle Responses to α1‐ and α2‐Adrenoceptor Agonists by Diltiazem and Verapamil

S. Z. Langer, N. Shepperson, I. Cavero, 1983 .

Presynaptic alpha-adrenoceptors and [3H]-noradrenaline overflow from the mouse was deferens [proceedings].

P. Nasmyth, N. Shepperson, I. Marshall, 1978, British journal of pharmacology.

Pre-synaptic alpha-adrenoceptors and the inhibition by uptake blocking agents of the twitch response of the mouse vas deferens [proceedings].

P. Nasmyth, N. Shepperson, I. Marshall, 1977, British Journal of Pharmacology.

Pre-synaptic alpha-adrenoceptor regulation of the twitch response of the mouse vas deferens [proceedings].

C. Nicholl, P. Nasmyth, N. Shepperson, 1977, British Journal of Pharmacology.

The effect of depletion of the noradrenaline content on the response of the mouse vas deferens to electrical stimulation and to tyramine [proceedings].

P. Nasmyth, N. Shepperson, I. Marshall, 1977, Journal of Physiology.

Prejunctional modulation of noradrenaline release by alpha 2-adrenoceptors: physiological and pharmacological implications in the cardiovascular system.

S. Z. Langer, N. Shepperson, 1982, Journal of cardiovascular pharmacology.

The natriuretic and diuretic efficacy of atriopeptidase inhibitors following intravenous and oral administration.

N. Shepperson, P. Ellis, P. Barclay, 1989, British journal of pharmacology.